Surgical Closure of Isolated Patent Ductus Arteriosus in Cenhosoa Antananarivo

Intravenous Paracetamol and Patent Ductus Arteriosus Closure

Background: Standard medical treatments for patent ductus arteriosus (PDA) closure are, including indomethacin/ibuprofen and surgical ligation. Nowadays, a new strategy to close PDA is the use of paracetamol. The present study aimed to describe the use of intravenous (IV) paracetamol for PDA closure in neonates who present a contraindication to ibuprofen or ibuprofen failure with no possibility...

Surgical Closure of the Patent Ductus Arteriosus.

The patent ductus arteriosus was first described by Galen. No thought was given to the surgical treatment of patients with persistently patent ducti until 1907, when Munro described a technique for their ligation. It was not until twenty-one years later that Gross of Boston successfully ligated a patent ductus arteriosus for the first time. Since the epochal operation by Gross increased attenti...

Closure of Small Patent Ductus Arteriosus by Occluding Detachable Coil

Transfemoral plug closure of patent ductus arteriosus.

A patent ductus arteriosus should be closed because of its hemodynamic significance and/or the risk of infective endocarditis. Mortality of surgery is low. In adults, however, technical problems can arise due to calcification of the ductus walls. Using the transfemoral plug technique, developed by Porstmann, we attempted a ductus closure without surgery on 35 patients. The youngest was an 11-ye...

Transcatheter Closure of Patent Ductus Arteriosus

Background The USCI PDA Umbrella is a device to close patent ductus arteriosus (PDA) by a transcatheter technique. Human clinical trials have shown excellent efficacy in reducing or eliminating the PDA shunt, but concerns remain about the risk of infection with this device. The purpose of this study was to evaluate the risk of infection using an animal model. Methods and Results Susceptibility ...